ABIOMED Inc (NASDAQ:ABMD)

281.38
Delayed Data
As of 4:00pm ET
 +2.80 / +1.00%
Today’s Change
119.01
Today|||52-Week Range
319.19
+64.95%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Medical Specialties
MARKET CAP
$12.9B

Company Description

ABIOMED, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It distributes its products under the Impella brand. The company was founded by David M. Lederman in 1981 and is headquartered in Danvers, MA.

Contact Information

ABIOMED, Inc.
22 Cherry Hill Drive
Danvers Massachusetts 01923
P:(978) 646-1400
Investor Relations:

Employees

Shareholders

Mutual fund holders57.64%
Other institutional40.40%
Individual stakeholders16.37%

Top Executives

Michael R. MinogueChairman, President & Chief Executive Officer
David M. WeberChief Operating Officer & Senior Vice President
Todd A. TrappChief Financial Officer & Vice President
Thorsten SießChief Technology Officer & Vice President
Charles A. SimontonChief Medical Officer & Vice President